EGFR-TKIs have been shown to exert their action by inhibiting the phosphorylation of Hsp70 and stimulating its ubiquitination in lung adenocarcinoma cells resulting in this protein’s degradation. The gene discussed is EGFR; the disease is lung adenocarcinoma.